258 related articles for article (PubMed ID: 23562557)
1. NOD2 mutations are associated with the development of intestinal failure in the absence of Crohn's disease.
Schäffler H; Schneider N; Hsieh CJ; Reiner J; Nadalin S; Witte M; Königsrainer A; Blumenstock G; Lamprecht G
Clin Nutr; 2013 Dec; 32(6):1029-35. PubMed ID: 23562557
[TBL] [Abstract][Full Text] [Related]
2. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
3. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide oligomerization domain 2 polymorphisms in patients with intestinal failure.
Guerra JF; Zasloff M; Lough D; Abdo J; Hawksworth J; Mastumoto C; Girlanda R; Island E; Shetty K; Kaufman S; Fishbein T
J Gastroenterol Hepatol; 2013 Feb; 28(2):309-13. PubMed ID: 23173613
[TBL] [Abstract][Full Text] [Related]
5. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
Lakatos L; Lakatos PL; Willheim-Polli C; Reinisch W; Ferenci P; Tulassay Z; Molnár T; Kovács A; Papp J; Szalay F;
Orv Hetil; 2004 Jul; 145(27):1403-11. PubMed ID: 15320482
[TBL] [Abstract][Full Text] [Related]
6. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.
Cleynen I; González JR; Figueroa C; Franke A; McGovern D; Bortlík M; Crusius BJ; Vecchi M; Artieda M; Szczypiorska M; Bethge J; Arteta D; Ayala E; Danese S; van Hogezand RA; Panés J; Peña SA; Lukas M; Jewell DP; Schreiber S; Vermeire S; Sans M
Gut; 2013 Nov; 62(11):1556-65. PubMed ID: 23263249
[TBL] [Abstract][Full Text] [Related]
7. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
[TBL] [Abstract][Full Text] [Related]
8. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
[TBL] [Abstract][Full Text] [Related]
9. The NOD2 p.Leu1007fsX1008 mutation (rs2066847) is a stronger predictor of the clinical course of Crohn's disease than the FOXO3A intron variant rs12212067.
Schnitzler F; Friedrich M; Wolf C; Angelberger M; Diegelmann J; Olszak T; Beigel F; Tillack C; Stallhofer J; Göke B; Glas J; Lohse P; Brand S
PLoS One; 2014; 9(11):e108503. PubMed ID: 25365249
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation.
Büning C; Genschel J; Bühner S; Krüger S; Kling K; Dignass A; Baier P; Bochow B; Ockenga J; Schmidt HH; Lochs H
Aliment Pharmacol Ther; 2004 May; 19(10):1073-8. PubMed ID: 15142196
[TBL] [Abstract][Full Text] [Related]
11. NOD2 gene mutations associate weakly with ulcerative colitis but not with Crohn's disease in Indian patients with inflammatory bowel disease.
Pugazhendhi S; Santhanam S; Venkataraman J; Creveaux I; Ramakrishna BS
Gene; 2013 Jan; 512(2):309-13. PubMed ID: 23085276
[TBL] [Abstract][Full Text] [Related]
12. The NOD2 Single Nucleotide Polymorphism rs72796353 (IVS4+10 A>C) Is a Predictor for Perianal Fistulas in Patients with Crohn's Disease in the Absence of Other NOD2 Mutations.
Schnitzler F; Friedrich M; Wolf C; Stallhofer J; Angelberger M; Diegelmann J; Olszak T; Tillack C; Beigel F; Göke B; Glas J; Lohse P; Brand S
PLoS One; 2015; 10(7):e0116044. PubMed ID: 26147989
[TBL] [Abstract][Full Text] [Related]
13. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
[TBL] [Abstract][Full Text] [Related]
14. Association of Crohn's disease-associated NOD2 variants with intestinal failure requiring small bowel transplantation and clinical outcomes.
Janse M; Weersma RK; Sudan DL; Festen EA; Wijmenga C; Dijkstra G; Mercer D
Gut; 2011 Jun; 60(6):877-8; author reply 878-9. PubMed ID: 20940282
[No Abstract] [Full Text] [Related]
15. Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2.
Abad C; González-Escribano MF; Diaz-Gallo LM; Lucena-Soto JM; Márquez JL; Leo E; Crivell C; Gómez-García M; Martín J; Núñez-Roldán A; García-Lozano JR
Genes Immun; 2011 Dec; 12(8):635-42. PubMed ID: 21716313
[TBL] [Abstract][Full Text] [Related]
16. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
[TBL] [Abstract][Full Text] [Related]
17. Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population.
Zhou Z; Lin XY; Akolkar PN; Gulwani-Akolkar B; Levine J; Katz S; Silver J
Am J Gastroenterol; 2002 Dec; 97(12):3095-101. PubMed ID: 12492195
[TBL] [Abstract][Full Text] [Related]
18. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
[TBL] [Abstract][Full Text] [Related]
19. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
[TBL] [Abstract][Full Text] [Related]
20. Is age of onset of Crohn's disease governed by mutations in NOD2/caspase recruitment domains 15 and Toll-like receptor 4? Evaluation of a pediatric cohort.
Leshinsky-Silver E; Karban A; Buzhakor E; Fridlander M; Yakir B; Eliakim R; Reif S; Shaul R; Boaz M; Lev D; Levine A
Pediatr Res; 2005 Sep; 58(3):499-504. PubMed ID: 16148063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
